← Back to Search

Gaido Intervention for Cancer

N/A
Waitlist Available
Led By Philip Lowry, MD
Research Sponsored by Gaido Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult oncology patients over the age of 18 who are receiving chemotherapy.
Adult oncology in-patients over the age of 18 who are being being discharged.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up evaluation last for 3 days after each patient use
Awards & highlights

Study Summary

The goal of this research is to study an intervention, which the investigators call "Remote Electronic Patient Monitoring," that entails vital sign data (enabled with smart algorithms for notification) and patient-reported outcomes (PROs), (such as physical and psychological symptoms) intended to address and manage any concerning issues and or diagnoses identified. Specifically, the plan is a study of oncology patients who will use the Gaido system for up to 21 days or per physician order.

Eligible Conditions
  • Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~evaluation last for 3 days after each patient use
This trial's timeline: 3 weeks for screening, Varies for treatment, and evaluation last for 3 days after each patient use for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of Gaido intervention for use by cancer patients
Secondary outcome measures
Acceptability of Gaido intervention for use by cancer patients
Malignant Neoplasms

Trial Design

1Treatment groups
Experimental Treatment
Group I: Gaido InterventionExperimental Treatment1 Intervention
All patients enrolled in the study will participate in the Gaido Intervention, which entails wearing the Biovotion Everion continuously and take blood pressure and oral temperature spot checks per clinician orders. Patients will also be responsible for filling out PRO surveys and any surveys that trigger as a result of their vital signs falling outside of tailored thresholds.

Find a Location

Who is running the clinical trial?

Gaido HealthLead Sponsor
The Guthrie ClinicOTHER
25 Previous Clinical Trials
1,838 Total Patients Enrolled
Philip Lowry, MDPrincipal InvestigatorGuthrie Medical Center
2 Previous Clinical Trials
3 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025